ATE116334T1 - Reagens und methode zum nachweis der wirksamkeit von retroviraler protease. - Google Patents

Reagens und methode zum nachweis der wirksamkeit von retroviraler protease.

Info

Publication number
ATE116334T1
ATE116334T1 AT90870250T AT90870250T ATE116334T1 AT E116334 T1 ATE116334 T1 AT E116334T1 AT 90870250 T AT90870250 T AT 90870250T AT 90870250 T AT90870250 T AT 90870250T AT E116334 T1 ATE116334 T1 AT E116334T1
Authority
AT
Austria
Prior art keywords
retroviral protease
effectiveness
reagent
detecting
protease
Prior art date
Application number
AT90870250T
Other languages
English (en)
Inventor
Garland Ross Marshall
Mihaly Vadkerti Toth
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE116334T1 publication Critical patent/ATE116334T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT90870250T 1989-12-28 1990-12-27 Reagens und methode zum nachweis der wirksamkeit von retroviraler protease. ATE116334T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/458,060 US5011910A (en) 1989-12-28 1989-12-28 Reagent and method for determining activity of retroviral protease

Publications (1)

Publication Number Publication Date
ATE116334T1 true ATE116334T1 (de) 1995-01-15

Family

ID=23819193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90870250T ATE116334T1 (de) 1989-12-28 1990-12-27 Reagens und methode zum nachweis der wirksamkeit von retroviraler protease.

Country Status (8)

Country Link
US (1) US5011910A (de)
EP (1) EP0435845B1 (de)
JP (1) JP2909225B2 (de)
AT (1) ATE116334T1 (de)
CA (1) CA2033254C (de)
DE (1) DE69015603T2 (de)
DK (1) DK0435845T3 (de)
ES (1) ES2069061T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801702D0 (sv) * 1988-05-05 1988-05-05 Pharmacia Ab Sett vid bestemning av enzymatisk aktivitet
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease
US5171662A (en) * 1990-09-13 1992-12-15 The Upjohn Company Method of detecting HIV protease activity
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5506115A (en) * 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
US5605809A (en) * 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
JP2863638B2 (ja) * 1996-01-26 1999-03-03 ベーリンガー マンハイム コーポレイション ビスーマレイミド架橋剤
US5976857A (en) * 1996-01-26 1999-11-02 Boehringer Mannheim Corporation Cross-linked polypeptide fragments of β-galactosidase
US5763196A (en) * 1996-01-26 1998-06-09 Boehringer Mannheim Corporation Assays using cross-linked polypeptide fragments of β-galactosidase
WO1997042216A1 (en) * 1996-04-24 1997-11-13 Peptide Therapeutics Limited Auto-deconvoluting combinatorial libraries
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US7312302B2 (en) 1997-02-20 2007-12-25 Oncolmmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
US6893868B2 (en) * 1997-02-20 2005-05-17 Onco Immunin, Inc. Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
US20060040319A1 (en) * 2000-01-14 2006-02-23 Tom Muir Multiple sensor-containing active modified polypeptides, preparation and uses thereof
GB0024351D0 (en) * 2000-10-04 2000-11-22 Amersham Pharm Biotech Uk Ltd Dye-labelled peptide and method
US7473678B2 (en) * 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR20080084808A (ko) * 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
ES2443581T3 (es) * 2006-02-09 2014-02-19 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en) * 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
AU2007269712B2 (en) 2006-06-30 2013-02-07 Biomimetic Therapeutics, Llc PDGF-biomatrix compositions and methods for treating rotator cuff injuries
WO2008073628A2 (en) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
AU2009212151C1 (en) * 2008-02-07 2015-09-17 Stryker Corporation Compositions and methods for distraction osteogenesis
BR122020000059B8 (pt) * 2008-09-09 2021-06-22 Biomimetic Therapeutics Inc composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
BRPI0923015A2 (pt) * 2008-12-19 2015-12-15 Biomimetic Therapeutics Inc enxertos ósseos com atividade de protease reduzida e métodos de seleção e uso
JP2012519556A (ja) * 2009-03-05 2012-08-30 バイオミメティック セラピューティクス， インコーポレイテッド 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法
BR112012020566B1 (pt) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384555A (en) * 1965-11-30 1968-05-21 Army Usa Direct fluorometric method for measuring dehydrogenase activity
DE3244030A1 (de) * 1982-11-27 1984-05-30 Behringwerke Ag, 3550 Marburg Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE3531778A1 (de) * 1985-09-06 1987-03-12 Behringwerke Ag Verfahren zur bestimmung von proteaseinhibitoren

Also Published As

Publication number Publication date
JPH04210598A (ja) 1992-07-31
DK0435845T3 (da) 1995-05-01
JP2909225B2 (ja) 1999-06-23
CA2033254A1 (en) 1991-06-29
US5011910A (en) 1991-04-30
DE69015603D1 (de) 1995-02-09
EP0435845A1 (de) 1991-07-03
CA2033254C (en) 2001-11-20
ES2069061T3 (es) 1995-05-01
EP0435845B1 (de) 1994-12-28
DE69015603T2 (de) 1995-06-22

Similar Documents

Publication Publication Date Title
ATE116334T1 (de) Reagens und methode zum nachweis der wirksamkeit von retroviraler protease.
ATE141649T1 (de) Verfahren zum nachweis von hydrolytischen enzymen
ATE121138T1 (de) Verfahren zum nachweis von mikroorganismen durch verwendung von resorufin oder orcirufin.
IT1070002B (it) Substrato cromogeno o fluorescente impiegabile come reagente per la determinazione quantitativa di enzimi proteolitici del gruppo e.c. 3.4.4.
DE3486254D1 (de) Verfahren zum aufspüren, identifizieren und quantifizieren von organismen und viren.
ATE35000T1 (de) Reagenz zur bestimmung der thromboplastinzeit.
DE69022255D1 (de) Beta-Lactamasetests mit Gebrauch von chromogenen Niederschlag bildenden Substraten.
DE3882078D1 (de) Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung.
DE3866251D1 (de) Spannvorrichtung zum halten einer kammer zum zentrifugieren von blut und aehnlichem.
ATE67520T1 (de) Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu.
DK163189C (da) Fremgangsmaade og reagens til bestemmelse af plasmas fibrinolytiske tilstand
ATE103327T1 (de) In vivo-markierung von polynucleotide-sequenzen.
ATA463976A (de) Verahren zur bestimmung von thrombin und thrombinartigen enzymen durch spaltung chromogene substrate
ES552374A0 (es) Un procedimiento para determinar la actividad de una hidrolasa macromolecular
DE3663684D1 (de) Determination of prokallikrein
DK0570354T3 (da) Fremgangsmåde til bestemmelse af fibrinogen
DE59309254D1 (de) Verwendung von Prothrombinfragmenten
ES2069635T3 (es) Procedimiento y reactivo para la determinacion de antitrombina iii.
DE3789102D1 (de) Bäder und Verfahren zum chemischen Polieren von rostfreien Stahloberflächen.
EP0369657A3 (de) Chromogenes Esterasesubstrat und dessen Verwendung in einem Immunoassay

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee